Carbidopa-levo ER 48.75-195 CP 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F9AWC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,595
Award facts
- Contract value 100% obligated
- $10,594.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,594.67 to AmerisourceBergen Drug Corp for the supply of Carbidopa-Levodopa Extended Release 48.75-195 mg capsules (100-count bottles) on December 4, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with the place of performance located at its corporate office in Pennsylvania.
This delivery order fulfills military healthcare pharmaceutical needs as part of DLA's comprehensive medical supply chain operations supporting the Defense Health Agency and other federal healthcare systems. Carbidopa-Levodopa is a neurological medication used primarily in the treatment of Parkinson's disease and is typical of the diverse pharmaceutical portfolio that AmerisourceBergen supplies through its prime vendor contract. The award reflects the competitive capability AmerisourceBergen has demonstrated through its extensive federal contract portfolio, positioning it as a key supplier within the Defense Logistics Agency's global pharmaceutical support framework.
Quick answers
Who was awarded contract SPE2DR26F9AWC?
SPE2DR26F9AWC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F9AWC worth?
The government has obligated $10,595 on SPE2DR26F9AWC.
Is contract SPE2DR26F9AWC an order under another contract?
Yes. SPE2DR26F9AWC is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9AWC competed?
The extent of competition for SPE2DR26F9AWC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award